Related references
Note: Only part of the references are listed.Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper
Xavier Bossuyt et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries
Delphine S. Courvoisier et al.
RHEUMATOLOGY (2021)
Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain
E. Eloff et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2021)
Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis
Josephine A. M. P. Amkreutz et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients
K. Roos Ljungberg et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)
Predictive values of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in relation to serological aspects of the ACR/EULAR 2010 classification criteria for rheumatoid arthritis
H. B. Tenstad et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2020)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications
T. Kissel et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound
Santiago Ruta et al.
CLINICAL RHEUMATOLOGY (2020)
Third-Generation Anti-Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid Arthritis
Andrea Di Matteo et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Autoantibodies to Malondialdehyde-Acetaldehyde Are Detected Prior to Rheumatoid Arthritis Diagnosis and After Other Disease Specific Autoantibodies
Ted R. Mikuls et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006-2011
M. Ziegelasch et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2020)
Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry
Nobunori Takahashi et al.
SCIENTIFIC REPORTS (2020)
Likelihood Ratios as Value Proposition for Diagnostic Laboratory Tests
Walter Fierz et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2020)
Quality and best practice in medical laboratories: specific requests for autoimmunity testing
Ulrich Sack et al.
AUTOIMMUNITY HIGHLIGHTS (2020)
Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies
Mark C. Genovese et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Screening for two or three autoantibodies in persons at risk for RA: implications of current data for clinical practice
Robin M. ten Brinck et al.
RHEUMATOLOGY (2019)
Recognition of Amino Acid Motifs, Rather Than Specific Proteins, by Human Plasma Cell-Derived Monoclonal Antibodies to Posttranslationally Modified Proteins in Rheumatoid Arthritis
Johanna Steen et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib
Paul Bird et al.
RMD OPEN (2019)
Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis
Lieve Van Hoovels et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Clinically relevant discrepancies between different rheumatoid factor assays
Willem J. J. Falkenburg et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Can an increase in autoantibody levels predict arthritis in arthralgia patients?
Marian H. van Beers-Tas et al.
RHEUMATOLOGY (2018)
Rheumatoid arthritis
Josef S. Smolen et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Standardization and harmonization of autoimmune diagnostics
Joannes F. M. Jacobs et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis
Emil Rydell et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants
Johan Ronnelid et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Diagnostic accuracy of anti-Sa and anti-RA33 antibodies in rheumatoid arthritis: a meta-analysis
Y. H. Lee et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2017)
Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis
Leendert A. Trouw et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia
Robin M. ten Brinck et al.
RHEUMATOLOGY (2017)
Association of the Presence of Anti-Carbamylated Protein Antibodies In Early Arthritis With a Poorer Clinical and Radiologic Outcome
Marie-Elise Truchetet et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis
Jiaqi Ren et al.
CLINICAL RHEUMATOLOGY (2017)
Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up
Vivek Anand Manivel et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Anticitrullinated protein antibodies: taking into account antibody levels improves interpretation
Xavier Bossuyt
ANNALS OF THE RHEUMATIC DISEASES (2017)
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients
Giovanni Orsolini et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms - a cohort study
Jacqueline L. Nam et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Predictive factors for induction of remission in patients with active rheumatoid arthritis treated with tocilizumab in clinical practice
Javier Narvaez et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis
Liubing Li et al.
PLOS ONE (2016)
Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies
Evan Reed et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis
Serena Bugatti et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Associations With Smoking and Shared Epitope Differ Between IgA- and IgG-Class Antibodies to Cyclic Citrullinated Peptides in Early Rheumatoid Arthritis
Anna Svard et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Malondialdehyde-Acetaldehyde Adducts and Anti-Malondialdehyde-Acetaldehyde Antibodies in Rheumatoid Arthritis
Geoffrey M. Thiele et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study
C. Rakieh et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
Nancy Agmon-Levin et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Clinical evaluation of a novel chemiluminescent immunoassay for the detection of anti-citrullinated peptide antibodies
Tyler Webb et al.
CLINICA CHIMICA ACTA (2014)
Comparison of anti-CCP autoantibodies measurement by ELISA and a bead-based assay in a large patient cohort
Raya Harich et al.
CLINICAL BIOCHEMISTRY (2014)
Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies
Eva Salgado et al.
JOINT BONE SPINE (2014)
The Status of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Are Not Associated with the Effect of Anti-TNFα Agent Treatment in Patients with Rheumatoid Arthritis: A Meta-Analysis
Qianwen Lv et al.
PLOS ONE (2014)
Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice
Yves-Marie Pers et al.
RHEUMATOLOGY (2014)
A prediction rule for the development of arthritis in seropositive arthralgia patients
Lotte Arwen van de Stadt et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Antibodies to modified citrullinated vimentin are associated with severe extra-articular manifestations in rheumatoid arthritis
Carl Turesson et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Brief Report: AntiCarbamylated Protein Antibodies Are Present in Arthralgia Patients and Predict the Development of Rheumatoid Arthritis
Jing Shi et al.
ARTHRITIS AND RHEUMATISM (2013)
Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis
R. J. Maneiro et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden
Lisbeth Arlestig et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Preliminary evaluation of the first international reference preparation for anticitrullinated peptide antibodies
Nicola Bizzaro et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Third generation anti-citrullinated peptide antibody assay is a sensitive marker in rheumatoid factor negative rheumatoid arthritis
Andreas Swart et al.
CLINICA CHIMICA ACTA (2012)
Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis
Carl Turesson et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Rheumatoid factor measurement-continuing problems 70 years after discovery
Rohan Ameratunga et al.
CLINICAL RHEUMATOLOGY (2011)
Multicentric evaluation of a second generation assay to detect antiviral citrullinated peptide antibodies: a collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni
N. Bizzaro et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Anti-CCP antibodies: the past, the present and the future
Walther J. van Venrooij et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage
Jing Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis
Hee Jung Ryu et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis
L. Damjanovska et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Rheumatoid Arthritis-Specific Autoantibodies to Peptidyl Arginine Deiminase Type 4 Inhibit Citrullination of Fibrinogen
Isabelle Auger et al.
ARTHRITIS AND RHEUMATISM (2010)
Long-Term Impact of Delay in Assessment of Patients With Early Arthritis
Michael P. M. van der Linden et al.
ARTHRITIS AND RHEUMATISM (2010)
Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor
X. Bossuyt et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory
Xavier Bossuyt
AUTOIMMUNITY REVIEWS (2009)
A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis
Lisiane Maria Enriconi dos Anjos et al.
CLINICAL RHEUMATOLOGY (2009)
Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis
Michelle L. Harris et al.
ARTHRITIS AND RHEUMATISM (2008)
Diagnostic accuracy of immunoassays for the detection of antibodies to citrullinated proteins
Nicola Bizzaro et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2008)
Antibodies against citrullinated vimentin in rheumatoid arthritis
Linda Mathsson et al.
ARTHRITIS AND RHEUMATISM (2008)
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis
Holger Bang et al.
ARTHRITIS AND RHEUMATISM (2007)
Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis
Snaevar Sigurdsson et al.
ARTHRITIS AND RHEUMATISM (2007)
Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis
Kunihiro Nishimura et al.
ANNALS OF INTERNAL MEDICINE (2007)
High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibodycontaining immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset
Mohammed Mullazehi et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis
Dries Coenen et al.
CLINICAL CHEMISTRY (2007)
Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis
C. Turesson et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
A new model for an etiology of rheumatoid arthritis
L Klareskog et al.
ARTHRITIS AND RHEUMATISM (2006)
Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
Christian Dejaco et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis:: anti-CP status predicts worse disease activity and greater radiological progression
J Rönnelid et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
A new approach to sample size calculation for reference interval studies
C Jennen-Steinmetz et al.
STATISTICS IN MEDICINE (2005)
A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis
FA van Gaalen et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases
AS Wiik
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2005)
Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis
M Schaller et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Specific autoantibodies precede the symptoms of rheumatoid arthritis - A study of serial measurements in blood donors
MMJ Nielen et al.
ARTHRITIS AND RHEUMATISM (2004)
Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)
A Kastbom et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis
F Jouen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Antibody response to the human stress protein BiP in rheumatoid arthritis
MD Bodman-Smith et al.
RHEUMATOLOGY (2004)
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis
S Rantapää-Dahlqvist et al.
ARTHRITIS AND RHEUMATISM (2003)
Detection of antibodies to deiminated recombinant rat. filaggrin by enzyme-linked immunosorbent assay -: A highly effective test for the diagnosis of rheumatoid arthritis
C Vincent et al.
ARTHRITIS AND RHEUMATISM (2002)
Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease
M Schaller et al.
NATURE IMMUNOLOGY (2001)
Share Paper
